randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 Randomised, double-blind, placebo-controlled, parallel-group, multicentric,
Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with The effects of l Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double blind, randomized, placebo controlled trial Clinical Nutrition ESPEN Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect A Placebo Controlled Trial of Acetyl L Carnitine and Lipoic Acid in the Treatment of Bipolar Depression PMC
Pay in 4 interest-free payments of $5.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




